TWO · 1777.TWO
SYN-TECH Chem. & Pharm. Co., Ltd.
NT$76.80+NT$0.30 (+0.39%)
SYN-TECH Chem. & Pharm. Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.42% below the high.
Loading market information…
TWO · 8403.TWO · TWD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
ShareHope Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 23.63% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
ShareHope Medicine Co., Ltd.’s forward annual dividend is NT$0.60 per share, paid annual. The forward yield is 3.2% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow ShareHope Medicine Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
ShareHope Medicine Co., Ltd., a company based in Taiwan, delivers a wide array of integrated healthcare solutions. Its operations encompass health management and administrative services, the provision of skilled medical professionals for staffing needs, and the distribution of various medical, pharmaceutical, and general health-related devices. The company also offers remote healthcare, often referred to as telemedicine, and facilitates the rental of essential medical equipment. ShareHope Medicine Co., Ltd. was established in 2003 and operates from its headquarters in Taoyuan City, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:27 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| NT$1.09B+1.09% vs estimate |
| Q1 2024 | May 10, 2024 | NT$0.19-74.18% vs estimate | NT$972.55M-12.22% vs estimate |
|---|
| Q4 2023 | Mar 15, 2024 | NT$0.35-46.73% vs estimate | NT$1.07B-1.21% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$76.80+NT$0.30 (+0.39%)
SYN-TECH Chem. & Pharm. Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.42% below the high.
NT$35.10-NT$1.00 (-2.77%)
Maxigen Biotech Inc.’s quoted price sits in the lower half of its reported 52-week range, 27.33% below the high.
NT$29.00-NT$0.75 (-2.52%)
Apex Biotechnology Corp.’s quoted price sits in the lower half of its reported 52-week range, 15.45% below the high.
NT$21.00-NT$0.05 (-0.24%)
Maywufa Company Ltd.’s quoted price sits in the upper half of its reported 52-week range, 5.83% below the high.
NT$73.00-NT$1.10 (-1.48%)
A Plus Biotechnology Co Ltd’s quoted price sits in the lower half of its reported 52-week range, 20.65% below the high.
NT$37.30-NT$0.20 (-0.53%)
Qing Song Health Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.32% below the high.
NT$83.40-NT$2.40 (-2.8%)
Syngen Biotech Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.85% below the high.
NT$28.50-NT$1.60 (-5.32%)
3D Global Biotech Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.66% below the high.
